已收盤 09-12 16:10:00
0.000
0.00%
TATA健康(01255.HK)公布2023年年度业绩,收入约2.075亿港元,同比增加约43.5%;公司拥有人应占亏损3229.4万港元,同比盈转亏;每股亏损0.13港元。
09-10 22:50
TATA健康(01255)公布2023年年度业绩,收入约2.075亿港元,同比增加...
09-10 22:42
ECARX Holdings Inc. (Nasdaq: ECX) launched a next-gen in-vehicle navigation system and Skyland® intelligent driving solution at IAA Mobility 2025, integrating HERE's navigation platform for global compliance and Black Sesame's chip for L2+ driving features. The solutions already support brands like Lotus, Lynk & Co, and Hongqi, with more models planned for late 2025. ECARX aims to accelerate automakers' feature rollout with scalable, globally com...
09-10 11:00
ECD Automotive Design unveils Project Oliver, a 1996 Land Rover Defender D110 Signature Edition, blending raw capability with luxury. Featuring a powerful LT1 V8 engine, 10-speed transmission, Brembo brakes, and custom Air Ride suspension, this vehicle excels in rugged terrains. Its sleek Obsidian Black Metallic exterior pairs with a bespoke interior, including premium black leather, Scheel-Mann Traveler seats, and advanced tech features like a t...
09-03 12:04
TATA健康(01255.HK)发布公告,经向接管人作出适当查询后,接管人表示彼等目前尚未物色到任何潜在买家购买抵押股份,且尚未达成任何买卖,亦未就任何可能出售抵押股份订立任何确实交易文件;彼等无法积极物色控股权(即本公司已发行股本的30%)(控股权)的潜在买家;及彼等并无与潜在买家就控股权进行磋商。
07-22 21:00
TATA健康(01255.HK)发布公告,苏嘉敏女已提呈辞任公司公司秘书,并不再担任香港联合交易所有限公司(联交所)证券上市规则第3.05条项下规定的公司授权代表(授权代表)以及香港法例第622章公司条例第16部及上市规则第19.05(2)条项下所规定的代表公司于香港接收法律程序文件及通知书的授权代表(法律程序文件代理人),均自2025年7月15日起生效。
07-15 21:10